Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use

The present invention provides for compounds of Formula (I)wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the inventi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hodges, Timothy R, Bogdan, Andrew, Schrimpf, Michael R, Li, Huan-Qiu, Hardee, David J, Korman, Henry
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Hodges, Timothy R
Bogdan, Andrew
Schrimpf, Michael R
Li, Huan-Qiu
Hardee, David J
Korman, Henry
description The present invention provides for compounds of Formula (I)wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024043386A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024043386A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024043386A13</originalsourceid><addsrcrecordid>eNqNjDEOgkAQRbexMOodJrE2QSDG1hCJDYlRqHHZHWQT2CE7Q-HtJeoBrF7x339L9SjITr0WCgzUgnQI2YvFGchdE4gdQxm05wGHZua8kreTEe0Nwg2f3y9cAwk6D9pbKFA6sp9cxbhWi1b3jJsfV2qbn8vsssORauRRG_QodXWPoziN0iQ5Hk775D_rDagkPgA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use</title><source>esp@cenet</source><creator>Hodges, Timothy R ; Bogdan, Andrew ; Schrimpf, Michael R ; Li, Huan-Qiu ; Hardee, David J ; Korman, Henry</creator><creatorcontrib>Hodges, Timothy R ; Bogdan, Andrew ; Schrimpf, Michael R ; Li, Huan-Qiu ; Hardee, David J ; Korman, Henry</creatorcontrib><description>The present invention provides for compounds of Formula (I)wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240208&amp;DB=EPODOC&amp;CC=US&amp;NR=2024043386A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240208&amp;DB=EPODOC&amp;CC=US&amp;NR=2024043386A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Hodges, Timothy R</creatorcontrib><creatorcontrib>Bogdan, Andrew</creatorcontrib><creatorcontrib>Schrimpf, Michael R</creatorcontrib><creatorcontrib>Li, Huan-Qiu</creatorcontrib><creatorcontrib>Hardee, David J</creatorcontrib><creatorcontrib>Korman, Henry</creatorcontrib><title>Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use</title><description>The present invention provides for compounds of Formula (I)wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEOgkAQRbexMOodJrE2QSDG1hCJDYlRqHHZHWQT2CE7Q-HtJeoBrF7x339L9SjITr0WCgzUgnQI2YvFGchdE4gdQxm05wGHZua8kreTEe0Nwg2f3y9cAwk6D9pbKFA6sp9cxbhWi1b3jJsfV2qbn8vsssORauRRG_QodXWPoziN0iQ5Hk775D_rDagkPgA</recordid><startdate>20240208</startdate><enddate>20240208</enddate><creator>Hodges, Timothy R</creator><creator>Bogdan, Andrew</creator><creator>Schrimpf, Michael R</creator><creator>Li, Huan-Qiu</creator><creator>Hardee, David J</creator><creator>Korman, Henry</creator><scope>EVB</scope></search><sort><creationdate>20240208</creationdate><title>Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use</title><author>Hodges, Timothy R ; Bogdan, Andrew ; Schrimpf, Michael R ; Li, Huan-Qiu ; Hardee, David J ; Korman, Henry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024043386A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>Hodges, Timothy R</creatorcontrib><creatorcontrib>Bogdan, Andrew</creatorcontrib><creatorcontrib>Schrimpf, Michael R</creatorcontrib><creatorcontrib>Li, Huan-Qiu</creatorcontrib><creatorcontrib>Hardee, David J</creatorcontrib><creatorcontrib>Korman, Henry</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hodges, Timothy R</au><au>Bogdan, Andrew</au><au>Schrimpf, Michael R</au><au>Li, Huan-Qiu</au><au>Hardee, David J</au><au>Korman, Henry</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use</title><date>2024-02-08</date><risdate>2024</risdate><abstract>The present invention provides for compounds of Formula (I)wherein R1 has any of the values defined in the specification, and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024043386A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T22%3A15%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Hodges,%20Timothy%20R&rft.date=2024-02-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024043386A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true